ARCHIVES

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

ORI Finds Researcher Falsified Records

February 9, 1996

Stem Cell Transplant More Effective than Chemotherapy

April 25, 2003

A. Lindo Patterson: Pioneer and Mentor

October 26, 2021

More DCT Concepts Approved By Advisors

July 10, 1992

DeVita Says Payline Compression Leading to More Decisions By Staff On Funding

June 28, 1985

Advisors Approve Lung Screening Trial Testing Spiral CT Vs. X-Ray, For $200M.

November 23, 2001